Status:
TERMINATED
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborating Sponsors:
AVVAA World Healthcare Products, Inc.
Conditions:
Psoriasis
Eczema
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.
Detailed Description
Subjects will apply study drug and placebo sprays 3 times a day to the assigned, randomized sides of the body. They are allowed to continue using prescription medications, but not moisturizers. Assess...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Must be at least 18 years of age
- Have psoriasis or eczema on both sides of the body, with a pair of roughly symmetrical bilateral "target" lesions at least 1.5 cm in diameter
- Exclusion Criteria
- Inability to understand the consent form and/or comply with the requirements of this study
- Use of moisturizers/emollients within 2 days of beginning study
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00143819
Start Date
September 1 2005
End Date
February 1 2010
Last Update
April 25 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.